Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia
This work was funded by Innovate UK grants (application numbers: 22217 and 10054602) and by Kinomica Ltd.
Authors
- Janet Kelsall
- Andrew Thompson (ORCID: https://orcid.org/0000-0003-3250-1603)
- Paolo Gallipoli (ORCID: https://orcid.org/0000-0001-7254-2253)
- Mark D. Minden (ORCID: https://orcid.org/0000-0002-9089-8816)
- Luís Nobre (ORCID: https://orcid.org/0000-0003-0467-8989)
- Alex J Ambinder
- A. Campbell (ORCID: https://orcid.org/0000-0001-8390-4360)
- Pedro R. Cutillas (ORCID: https://orcid.org/0000-0002-3426-2274)
- Weronika E. Borek (ORCID: https://orcid.org/0000-0001-5805-9986)
- Josie A. Christopher (ORCID: https://orcid.org/0000-0001-7077-4894)
- Andrew Williamson (ORCID: https://orcid.org/0000-0002-3861-4847)
- John G. Gribben (ORCID: https://orcid.org/0000-0002-8505-7430)
- Gabriel Ghiaur (ORCID: https://orcid.org/0000-0002-3955-7944)
- Bela Patel (ORCID: https://orcid.org/0000-0001-5804-5226)
- Andrea Arruda (ORCID: https://orcid.org/0000-0003-2516-8005)
- Harriet R. Ferguson (ORCID: https://orcid.org/0000-0002-0283-4629)
- Arran Dokal (ORCID: https://orcid.org/0000-0002-1447-0359)
- Pedro Moreno-Cardoso
- David N. Perkins
- David J. Britton
- S Federico Pedicona
- Nazrath Nawaz
Institutions
- AstraZeneca (United Kingdom) (GB)
- University Health Network (CA)
- Queen Mary University of London (GB)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Sidney Kimmel Comprehensive Cancer Center (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105316
- Citations
- 4
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Innovate UK